Gut Microbiota in Hypertension Research

Hypertension is a major risk factor for cardiovascular diseases and is associated with a variety of metabolic disorders. Emerging evidence suggests that the gut microbiota plays a significant role in regulating blood pressure and influencing the pathophysiology of hypertension. This research aims to investigate the complex relationship between gut microbiota composition and hypertension, exploring how microbial populations might affect blood pressure regulation and contribute to the development of hypertension. By understanding these interactions, the study hopes to provide insights into potential microbiota-based therapeutic strategies for managing or preventing hypertension. The findings could pave the way for novel approaches to treating high blood pressure through dietary interventions, probiotics, or other microbiome-targeted therapies.

高血压（Hypertension）是心血管疾病的主要危险因素，且与多种代谢紊乱密切相关。越来越多的研究证据表明，肠道菌群(gut microbiota)在调控血压以及影响高血压的病理生理进程中发挥着关键作用。本研究旨在探究肠道菌群组成与高血压之间的复杂关联，解析微生物群落如何影响血压调控并参与高血压的发生发展过程。通过阐明上述相互作用机制，本研究期望为开发用于管理或预防高血压的潜在菌群靶向治疗策略提供理论支撑。该研究成果有望为通过膳食干预、益生菌或其他菌群靶向疗法治疗高血压的创新方案开辟全新路径。